Ticker
VYNECompany Name
VYNE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash Return on Invested Capital | Free Cash Flow | Invested Capital |
---|---|---|---|
6/30/2025 | -102.53% | $ -39.89M | $ 38.91M |
3/31/2025 | -85.01% | $ -37.57M | $ 44.2M |
12/31/2024 | -65.32% | $ -34.09M | $ 52.19M |
9/30/2024 | -47.3% | $ -30.11M | $ 63.66M |
6/30/2024 | -35.66% | $ -26.75M | $ 75.01M |
3/31/2024 | -33.33% | $ -27.84M | $ 83.55M |
12/31/2023 | -28.49% | $ -25.34M | $ 88.95M |
9/30/2023 | -209.29% | $ -24.08M | $ 11.51M |
6/30/2023 | -150.83% | $ -26.05M | $ 17.27M |
3/31/2023 | -93.46% | $ -24.7M | $ 26.43M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Inv. Capital
(=) CROIC
CROIC for VYNE THERAPEUTICS INC is calculated as follows: FCF [ $ -128.23M ] / Inv. Capital [ $ 84.72M ]
(=) CROIC [ -151.36% ]
Minimum
Sep 30, 2023
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.46K |
---|---|
min | -43.78% |
max | 49.57% |
average | 2.84% |
median | 5.02% |
std | 15.02% |